Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion

Leukemia Research

Volumn 30, Issue 12, 2006, Pages 1493-1498

  Jootar, Saengsuree ^a   Pornprasertsud, Nida ^a   Petvises, Sawang ^c   Rerkamnuaychoke, Busaba ^a   Disthabanchong, Sinee ^a   Pakakasama, Samart ^a   Ungkanont, Artit ^a   Hongeng, Suradej ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c THAMMASAT UNIVERSITY   (Thailand)

Author keywords

Chronic myeloid leukemia; Mesenchymal stem cell; Philadelphia chromosome

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ADULT; ALLOIMMUNITY; ARTICLE; BONE MARROW; BONE MARROW CELL; CELL DIFFERENTIATION; CELL ISOLATION; CHROMOSOME ISOLATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; MONONUCLEAR CELL; OSTEOBLAST; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

ADOLESCENT; ADULT; BONE MARROW CELLS; CELL SEPARATION; CELLS, CULTURED; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID, CHRONIC; MALE; MESENCHYMAL STEM CELLS; MIDDLE AGED; PHILADELPHIA CHROMOSOME;

EID: 33750028977     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.04.013     Document Type: Article

References (28)

1. Rowley J.D. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining (letter). Nature 243 (1973) 290-293
2. Groffen J., Stephenson J.R., Heisterkamp N., de Klein A., Bartram C.R., and Grosveld G. Philadelphia chromosomal breakpoint are clustered within a limited region, bcr, on chromosome 22. Cell 36 (1984) 93-99
3. Raskind W.H., and Fialkow P.J. The use of cell markers in the study of human hematopoietic neoplasia. Adv Cancer Res 49 (1987) 127-167
4. Melo J.V., Gordon D.E., Cross N.C., and Goldman J.M. The ABL-BCR fusion gene is expressed in chronic myeloid leukemia. Blood 81 (1993) 158-165
5. Fialkow P.J., Jacobson R.J., and Papayannopoulou T. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med 63 (1977) 125-130
6. Coulombe L., Kalousek D.K., Eaves C.J., Gupta C.M., and Eaves A.C. Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. N Engl J Med 308 (1983) 1493-1498
7. Petzer A.L., Eaves C.J., Lansdorp P.M., Ponchio L., Barnett M.J., and Eaves A.C. Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia. Blood 88 (1996) 2162-2171
8. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cellc. Science 284 (1999) 143-147
9. Le Blanc, Tammik C., Rosendahl K., Zetterberg E., and Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31 (2003) 890-896
10. Petzer A.L., and Gunsilius E. Hematopoietic stem cells in chronic myeloid leukaemia. Arch Med Res 34 (2003) 496-506
11. Bruder S.P., Jaiswal N., and Haynesworth S.E. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64 (1997) 278-294
12. Maniatopoulos C., Sodek J., and Melcher A.H. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 254 (1988) 317-330
13. Aubin J.E. Regulation of osteoblast formation and function. Rev Endocr Metab Disord 2 (2001) 81-94
14. Kurzrock R., Gutterman J.U., and Talpaz. The molecular genetics of Philadelphia chromosome positive leukemia. New Engl J Med 319 (1988) 990-998
15. Goldman J.M., Grosveld G., Baltimore D., and Gale R.P. Chronic myelogenous leukemia-the unfolding saga. Leukemia 4 (1990) 163-167
16. Knopka J.B., Watanabe S.M., and Witte O.N. An alteration of human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell (1984) 1035-1042
17. Gordon M.Y., Dowding C.R., Riley G.P., Goldman J.M., and Greaves M.F. Altered adhesive intereactions with marrow stroma of hematopoietic progenitor cells in chronic myelogenous leukemia. Nature 328 (1987) 342-344
18. Bhatia R., McGlave P.B., Dewald G.W., Blazar B.R., and Verfaillie C.M. Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: Role of malignant stromal macrophages. Blood 85 (1995) 3636-3645
19. Horwitz E.M., Prockop D.J., Fitzpatrick L.A., Koo W.W.K., Gordon P.L., Neel M., et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children. Nat Med 5 (1999) 309-313
20. Koç O.N., and Lazatus H.M. Mesenchymal stem cells: heading into the clinic. Bone Marrow Transplant 27 (2001) 235-239
21. Angelopoulou M., Novelli E., Grove J.E., Rinder H.M., Civin C., Cheng L., et al. Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp Hematol 31 (2003) 413-420
22. Simmons P.J., Przepiorka D., Thomas E.D., and Torok-Storb B. Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature 328 (1987) 429-432
23. Hongeng S., Petvises S., Rerkamnuaychoke B., Worapongpaiboon S., Tardtong P., Apibal S., et al. Host origin of marrow mesenchymal stem cells following allogeneic cord-blood stem-cell transplantation. Int J Hematol 74 (2001) 235-236
24. Deans R.J., and Moseley A.B. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol. 28 (2000) 875-884
25. Le Blanc K., Rasmusson I., Sundberg B., Götherström C., Hassan M., Uzunel M., et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363 (2004) 1439-1441
26. Zeiser R., Marks R., Bertz H., and Finke J. Immunopathogenesis of acute graft-versus-host disease: implications for novel preventive and therapeutic strategies. Ann Hematol 83 (2004) 551-565
27. Lazarus H.M., Haynesworth S.E., Gerson S.L., Rosenthal N.S., and Caplan A.I. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 16 (1995) 557-564
28. Lazarus H., Curtin P., and Devine S. Role of mesenchymal stem cells (MSC) in allogeneic transplantation: early phase I clinical results (abstract). Blood 392 (2000) 1691